We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

114 hedge funds and large institutions have $142M invested in Inovio Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

72% more call options, than puts

Call options by funds: $5.94M | Put options by funds: $3.46M

32% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 31

9% more funds holding

Funds holding: 105 → 114 (+9)

0.14% more ownership

Funds ownership: 3.26% → 3.4% (+0.14%)

26% less capital invested

Capital invested by funds: $192M → $142M (-$50.3M)

Holders
114
Holders Change
+9
Holders Change %
+8.57%
% of All Funds
3.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
41
Reduced
31
Closed
9
Calls
$5.94M
Puts
$3.46M
Net Calls
+$2.48M
Net Calls Change
+$3.8M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$3.14M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.98M
3
ARTA
A.R.T. Advisors
New York
+$2.07M
4
Capstone Investment Advisors
Capstone Investment Advisors
New York
+$1.82M
5
RCM
Rotella Capital Management
Washington
+$1.65M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.66M
2
CA
Commerzbank Aktiengesellschaft
Germany
-$3.59M
3
IG
ING Group
Netherlands
-$2.2M
4
SM
Sabby Management
Florida
-$1.22M
5
GC
Globeflex Capital
California
-$996K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
26
Putnam Investments
Massachusetts
$934K – – –
SGAM
27
Smith Group Asset Management
Texas
$867K -$261 -3 -0%
PAM
28
Panagora Asset Management
Massachusetts
$863K +$85.1K +977 +9%
Creative Planning
29
Creative Planning
Kansas
$857K +$12.4K +142 +1%
UBS Group
30
UBS Group
Switzerland
$825K +$124K +1,421 +14%
CA
31
Commerzbank Aktiengesellschaft
Germany
$818K -$3.59M -41,148 -78%
Charles Schwab
32
Charles Schwab
California
$813K – – –
Group One Trading
33
Group One Trading
Illinois
$794K +$72.4K +831 +8%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$756K -$2.88K -33 -0.3%
Citigroup
35
Citigroup
New York
$740K +$475K +5,454 +105%
ERSOT
36
Employees Retirement System of Texas
Texas
$717K +$363K +4,166 +68%
TA
37
Teachers Advisors
New York
$666K +$2.18K +25 +0.3%
AL
38
Airain Ltd
Guernsey
$663K +$833K +9,565 New
IG
39
ING Group
Netherlands
$618K -$2.2M -25,302 -74%
Swiss National Bank
40
Swiss National Bank
Switzerland
$523K +$102K +1,166 +18%
AllianceBernstein
41
AllianceBernstein
Tennessee
$476K – – –
RTS
42
Round Table Services
New Jersey
$425K – – –
CCMU
43
Cheyne Capital Management (UK)
United Kingdom
$404K -$653K -7,500 -56%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$380K +$5.66K +65 +1%
Wells Fargo
45
Wells Fargo
California
$379K -$2.09K -24 -0.4%
Deutsche Bank
46
Deutsche Bank
Germany
$361K +$327K +3,753 +255%
ProShare Advisors
47
ProShare Advisors
Maryland
$358K -$33.3K -382 -7%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$354K – – –
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$351K – – –
AIG
50
American International Group
New York
$351K +$3.83K +44 +0.9%
1
2
3 4 5

INO Hedge Fund Activity: Q3 2015 in Review

114 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2015, worth a combined $142M — down 26% from $192M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new INO positions and 9 closed out — a net gain of 9 holders — while 41 added to existing stakes and 31 trimmed.

The largest buyer was State Street, adding an estimated $3.14M. The largest seller was Susquehanna International Group, cutting an estimated $5.66M.

  • 114 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2015, up from 105 in Q2 2015.
  • Funds reported $142M of Inovio Pharmaceuticals stock for Q3 2015, down 26% quarter-over-quarter.
  • 18 funds opened new Inovio Pharmaceuticals positions in Q3 2015 and 9 closed out, a net change of +9 holders.
  • The largest Inovio Pharmaceuticals buyer in Q3 2015 was State Street, an estimated $3.14M added.
  • The largest Inovio Pharmaceuticals seller in Q3 2015 was Susquehanna International Group, an estimated $5.66M sold.

Based on aggregated 13F filings for Q3 2015.